PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（药物流行病学和药物安全杂志）影响因子_期刊投稿发表

期刊简介

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.Particular areas of interest include:design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;assessments of harm versus benefit in drug therapy;patterns of drug utilization;relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

药物流行病学和药物安全的目的是为药物流行病学学科的数据、方法和观点的交流和评估提供一个国际论坛。该杂志发表原创研究的同行评审报告、特邀评论和各种客座社论和评论，涵盖药物流行病学的科学、医学、统计、法律的和经济方面以及药物安全性的上市后监测。这些类别中的适当材料也可考虑作为简要报告发表，特别关注的领域包括：研究特定药物、生物制剂或医疗器械的获益或安全性的研究的设计、分析、结果和解释，包括药物警戒、上市后监测、药物经济学、患者安全性、分子药物流行病学或药物流行病学广泛领域内的任何其他研究;与药品、生物制品和医疗器械相关的比较有效性研究。比较有效性研究是指生成和综合证据，比较预防、诊断、治疗和监测临床状况的替代方法的获益和危害，因为这些方法在真实的世界中确实使用;与药物流行病学相关的方法学贡献，无论是原创贡献、现有方法的综述，还是如何应用药物流行病学方法的指南;评估药物治疗的危害与获益;药物使用模式;药物流行病学与制定和解释监管指南之间的关系;评价与药品、生物制品和医疗器械相关的风险管理计划和方案。

《PHARMACOEPIDEMIOLOGY AND DRUG SAFETY》期刊已被查看：次

分区信息